Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CliniMACS T-cell Depleted Stem Cell Transplants for Hematologic Malignancies
NCT01119066Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- May 2010
- Primary completion
- Mar 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CD34+ enriched hematopoietic stem cells in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), multiple myeloma (MM), chronic myeloid leukemia (CML), sponsored by Memorial Sloan Kettering Cancer Center. Started May 2010; status: completed.
02
Drugs
CD34+ enriched hematopoietic stem cells
03
Conditions
acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)multiple myeloma (MM)chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT01119066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01119066.